Fat pad atrophy is an underdiagnosed cause of chronic heel pain, often mistaken for plantar fasciitis. The heel fat pad plays a crucial role in shock absorption, and its degeneration increases mechanical stress on the calcaneus, leading to pain and functional limitations. This short report on fat pad syndrome was conducted, focusing on clinical presentation, imaging techniques (ultrasound, MRI), and treatment strategies, including footwear and regenerative therapies. Fat pad syndrome is frequently misdiagnosed, resulting in delayed appropriate treatment. Imaging helps distinguish it from plantar fasciitis. Conservative management includes shock-absorbing footwear and orthotics, while regenerative therapies, such as fat grafting and PRP, show promise. Running shoes with thick cushioning and a low heel-to-toe drop (≤4 mm) may help redistribute plantar pressure effectively. A low-drop shoe encourages a midfoot or forefoot strike, reducing strain on hip and knee joints and promoting a more natural running technique. For example, Altra pioneered the “zero-drop” design, while brands such as Saucony (Guide series, 4–8 mm), New Balance (X Kaiha Road, 4 mm), and Hoka (Bondi, ~5 mm) all provide commercially available models. Recognizing fat pad syndrome is essential for accurate diagnosis and treatment. Advanced imaging and a multidisciplinary approach, including biomechanical interventions, can improve patient outcomes.
Tedeschi et al. (Mon,) studied this question.